导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -0.75% | 2538/4773 |
| 近一周 | -1.74% | 3212/5467 |
| 近一月 | -5.19% | 2222/5421 |
| 近一季 | -7.36% | 2321/5238 |
| 近半年 | -1.10% | 1854/4931 |
| 近一年 | 1.64% | 2214/4400 |
| 近两年 | 46.30% | 1597/2954 |
| 近三年 | 29.44% | 1087/2253 |
| 成立以来 | 46.67% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.50% 3249/4961 |
12.29% 2197/5312 |
- - |
- - |
| 2025 | 20.10% 2148/4813 |
-0.93% 2477/3635 |
2.26% 1703/4076 |
18.01% 2371/4524 |
0.46% 1987/4813 |
| 2024 | 16.41% 814/3463 |
2.77% 706/2808 |
-0.98% 885/3014 |
16.29% 1488/3129 |
-1.63% 1775/3463 |
| 2023 | -8.73% 1052/2656 |
4.27% 1002/2280 |
-3.82% 911/2385 |
-2.93% 792/2515 |
-6.25% 1693/2655 |
| 2022 | -18.69% 745/2207 |
-13.80% 840/1919 |
6.71% 626/2016 |
-13.27% 871/2113 |
1.92% 1087/2208 |
| 2021 | -1.69% 815/1822 |
-2.54% 664/1255 |
4.71% 853/1330 |
-5.20% 785/1466 |
1.61% 862/1822 |
| 2020 | 30.70% 516/1250 |
-9.55% 688/1028 |
13.18% 642/1067 |
12.86% 359/1164 |
13.13% 390/1184 |
| 2019 | 35.44% 377/1092 |
26.37% 414/739 |
-0.20% 227/788 |
0.67% 487/850 |
6.68% 574/918 |
| 2018 | - - |
- - |
- - |
-0.87% 204/660 |
-11.90% 379/682 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 港股医疗ETF | 1.4796 | 32.41% |
| 港股通药 | 0.9109 | 32.37% |
| 万家中证港股通创新药ETF | 1.6293 | 32.25% |
| 景顺长城中证港股通创新药ETF | 1.6918 | 32.17% |
| 天弘恒生沪深港创新药精选50ETF | 0.8599 | 32.08% |
| 港股医疗 | 0.9703 | 31.90% |
| 港医疗 | 0.9212 | 31.83% |
| 港股通医疗ETF工银 | 0.9798 | 31.81% |
| 港股通医疗ETF华宝 | 0.9918 | 31.64% |
| 万家中证港股通创新药ETF发起式联接A | 1.4193 | 31.06% |
| 平安300ETF联接A VS. 长安沪深300非周期A(740101) |